- MyIllumina
- Tools
The four-sample HumanOmni1-Quad BeadChip contains strategically selected content that includes markers derived from the 1,000 Genomes Project, all three HapMap phases, and recently published studies. Each BeadChip features over one million available assays per sample, containing carefully selected markers that deliver dense genome-wide coverage. Intelligent tag SNP selection has been optimized to maintain comprehensive genomic coverage, while reducing tag SNP redundancy. This has enabled the inclusion of additional content carefully chosen to target high-value regions of the genome associated with human disease.
View the product support page for additional technical information ยป
View the Omni Family of Microarrays »
Catalog IDs: WG-311-1110, WG-311-1111, WG-311-1112, WG-311-1113, WG-311-1123, WG-311-1124
Product Literature
| HumanOmni1-Quad Data Sheet |
| Omni Microarrays Brochure |
| Omni Whole-Genome Arrays Data Sheet |
Innovative technologies
At Illumina, our goal is to apply innovative technologies and revolutionary assays to the analysis of genetic variation and function, making studies possible that were not even imaginable just a few years ago. These studies will help make the realization of personalized medicine possible. With such rapid advances in technology taking place, it is mission critical to have solutions that are not only innovative, but flexible, scalable, and complete with industry-leading support and service. As a global company that places high value on collaborative interactions, rapid delivery of solutions, and prioritizing the needs of its customers, we strive to meet this challenge. Illumina's innovative, array-based solutions for DNA, RNA, and protein analysis serve as tools for disease research, drug development, and the development of molecular tests in the clinic.
At Illumina, our goal is to apply innovative technologies and revolutionary assays to the analysis of genetic variation and function, making studies possible that were not even imaginable just a few years ago. These studies will help make the realization of personalized medicine possible. With such rapid advances in technology taking place, it is mission critical to have solutions that are not only innovative, but flexible, scalable, and complete with industry-leading support and service. As a global company that places high value on collaborative interactions, rapid delivery of solutions, and prioritizing the needs of its customers, we strive to meet this challenge. Illumina's innovative, array-based solutions for DNA, RNA, and protein analysis serve as tools for disease research, drug development, and the development of molecular tests in the clinic.
© 2012 Illumina, Inc. All rights reserved.